Early Detection of Subclinical Myocardial Damage in Chronic Aortic Regurgitation and Strategies for Timely Treatment of Asymptomatic Patients

A series of hemodynamic and pathological responses occur in chronic aortic regurgitation, which eventually result in myocardial fibrosis and irreversible left ventricular dysfunction. According to guidelines, valvular surgery is recommended with the development of symptoms, left ventricular systolic dysfunction, or left ventricular dilatation. The optimal timing of surgical intervention has recently been questioned with documentation of irreversible myocardial damage resulting in incomplete left ventricular recovery and adverse clinical outcomes after surgery. Recognizing the shortcomings of the guidelines, we performed a comprehensive review on the novel diagnostic methods that have been shown to improve the detection of subclinical ventricular dysfunction in chronic aortic regurgitation and to improve prediction of outcomes.

[1]  Helmut Baumgartner,et al.  [2017 ESC/EACTS Guidelines for the management of valvular heart disease]. , 2017, Kardiologia polska.

[2]  L. Fleisher,et al.  2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.

[3]  Yuchi Han,et al.  Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. , 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[4]  E. Frangou,et al.  Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study. , 2016, European heart journal.

[5]  M. Desai,et al.  Aortic Cross-Sectional Area/Height Ratio and Outcomes in Patients With a Trileaflet Aortic Valve and a Dilated Aorta , 2016, Circulation.

[6]  S. Urheim,et al.  Exercise capacity and peak oxygen consumption in asymptomatic patients with chronic aortic regurgitation. , 2016, International journal of cardiology.

[7]  S. Urheim,et al.  Controlled release metoprolol for aortic regurgitation: a randomised clinical trial , 2015, Heart.

[8]  B. Gerber,et al.  Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T , 2015, Journal of Cardiovascular Magnetic Resonance.

[9]  S. Park,et al.  Left Ventricular Strain as Predictor of Chronic Aortic Regurgitation , 2015, Journal of cardiovascular ultrasound.

[10]  Jeroen J. Bax,et al.  Detection of subtle left ventricular systolic dysfunction in patients with significant aortic regurgitation and preserved left ventricular ejection fraction: speckle tracking echocardiographic analysis. , 2015, European heart journal cardiovascular Imaging.

[11]  F. Meijboom,et al.  Wytyczne ESC dotyczące rozpoznawania i leczenia chorób aorty w 2014 roku , 2014 .

[12]  B. Gerber,et al.  Prognostic significance of LGE by CMR in aortic stenosis patients undergoing valve replacement. , 2014, Journal of the American College of Cardiology.

[13]  T. Sundt,et al.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[14]  Thoralf M Sundt,et al.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.

[15]  G. Filardo,et al.  The STS AVR+CABG composite score: a report of the STS Quality Measurement Task Force. , 2014, The Annals of thoracic surgery.

[16]  B. Griffin,et al.  Decision Making in Asymptomatic Aortic Regurgitation in the Era of Guidelines: Incremental Values of Resting and Exercise Cardiac Dysfunction , 2014, Circulation. Cardiovascular imaging.

[17]  E. Nylander,et al.  Exercise echocardiography predicts postoperative left ventricular remodeling in aortic regurgitation , 2014, Scandinavian cardiovascular journal : SCJ.

[18]  Hong Tang,et al.  Value of three-dimensional speckle-tracking in detecting left ventricular dysfunction in patients with aortic valvular diseases. , 2013, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[19]  M. Enriquez-Sarano,et al.  Contractile reserve determined on exercise echocardiography in patients with severe aortic regurgitation. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[20]  Shou-guo Yang,et al.  [The predictive value of DE-CMR in patients with severe chronic aortic regurgitation and extremely dilated left ventricular chamber]. , 2012, Zhonghua wai ke za zhi [Chinese journal of surgery].

[21]  G. Di Salvo,et al.  Usefulness of bidimensional strain imaging for predicting outcome in asymptomatic patients aged ≤ 16 years with isolated moderate to severe aortic regurgitation. , 2012, The American journal of cardiology.

[22]  J. Francis,et al.  Aortic Regurgitation Quantification Using Cardiovascular Magnetic Resonance: Association With Clinical Outcome , 2012, Circulation.

[23]  D. Lachance,et al.  Effects of spironolactone treatment on an experimental model of chronic aortic valve regurgitation. , 2012, The Journal of heart valve disease.

[24]  D. Žaliaduonytė-Pekšienė,et al.  Components of left ventricular ejection and filling in patients with aortic regurgitation assessed by speckle-tracking echocardiography. , 2012, Medicina.

[25]  H. Ihlen,et al.  Detection of left ventricular dysfunction by global longitudinal systolic strain in patients with chronic aortic regurgitation. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[26]  D. Žaliaduonytė-Pekšienė,et al.  Left ventricular mechanics in asymptomatic normotensive and hypertensive patients with aortic regurgitation. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[27]  O. Nielsen,et al.  Speckle-tracking echocardiography for predicting outcome in chronic aortic regurgitation during conservative management and after surgery. , 2011, JACC. Cardiovascular imaging.

[28]  M. Ergelen,et al.  Comparison of Left Ventricular Contractility in Pressure and Volume Overload: A Strain Rate Study in the Clinical Model of Aortic Stenosis and Regurgitation , 2010, Echocardiography.

[29]  C. Rochitte,et al.  Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. , 2010, Journal of the American College of Cardiology.

[30]  E. Nylander,et al.  Preoperative longitudinal left ventricular function by tissue Doppler echocardiography at rest and during exercise is valuable in timing of aortic valve surgery in male aortic regurgitation patients. , 2010, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[31]  Y. Tayyareci,et al.  Subclinical Left Ventricular Dysfunction in Asymptomatic Severe Aortic Regurgitation Patients with Normal Ejection Fraction: A Combined Tissue Doppler and Velocity Vector Imaging Study , 2010, Echocardiography.

[32]  P. Oberti,et al.  Prospective validation of the prognostic usefulness of B-type natriuretic peptide in asymptomatic patients with chronic severe aortic regurgitation. , 2009, Journal of the American College of Cardiology.

[33]  M. Beer,et al.  Impact of Myocardial Fibrosis in Patients With Symptomatic Severe Aortic Stenosis , 2009, Circulation.

[34]  P. Varadarajan,et al.  Effect of beta-blocker therapy on survival in patients with severe aortic regurgitation results from a cohort of 756 patients. , 2009, Journal of the American College of Cardiology.

[35]  C. Hamm,et al.  Diagnostic and prognostic value of N-terminal pro B-type natriuretic peptide (NT-proBNP) in patients with chronic aortic regurgitation. , 2008, International journal of cardiology.

[36]  E. Fox,et al.  Epidemiology of pure valvular regurgitation in the large middle-aged African American cohort of the Atherosclerosis Risk in Communities study. , 2007, American heart journal.

[37]  S. Kyrzopoulos,et al.  Ventricular long-axis contraction as an earlier predictor of outcome in asymptomatic aortic regurgitation. , 2007, The American journal of cardiology.

[38]  A. Kerr,et al.  B-type natriuretic peptide and left ventricular dysfunction on exercise echocardiography in patients with chronic aortic regurgitation , 2007, Heart.

[39]  J. Ridgway,et al.  Myocardial T1 mapping for detection of left ventricular myocardial fibrosis in chronic aortic regurgitation: pilot study. , 2006, AJR. American journal of roentgenology.

[40]  J. Gardin,et al.  Burden of valvular heart diseases: a population-based study , 2006, The Lancet.

[41]  S. Kyrzopoulos,et al.  The role of left ventricular long-axis contraction in patients with asymptomatic aortic regurgitation. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[42]  A. Evangelista,et al.  Long-term vasodilator therapy in patients with severe aortic regurgitation. , 2005, The New England journal of medicine.

[43]  R. Scognamiglio,et al.  Long-term survival and functional results after aortic valve replacement in asymptomatic patients with chronic severe aortic regurgitation and left ventricular dysfunction. , 2005, Journal of the American College of Cardiology.

[44]  Philippe Ravaud,et al.  A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. , 2003, European heart journal.

[45]  D J Wheatley,et al.  Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses , 2003, Heart.

[46]  M. Enriquez-Sarano,et al.  Outcomes After Aortic Valve Replacement in Patients With Severe Aortic Regurgitation and Markedly Reduced Left Ventricular Function , 2002, Circulation.

[47]  E Fleck,et al.  Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease. , 2001, Journal of the American College of Cardiology.

[48]  E. DeLong,et al.  Prediction of operative mortality after valve replacement surgery. , 2001, Journal of the American College of Cardiology.

[49]  A. Fraser,et al.  Assessment of left ventricular long axis contraction can detect early myocardial dysfunction in asymptomatic patients with severe aortic regurgitation , 2001, Heart.

[50]  T. Marwick,et al.  Exercise echocardiography predicts development of left ventricular dysfunction in medically and surgically treated patients with asymptomatic severe aortic regurgitation , 2000, Heart.

[51]  W G Henderson,et al.  Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. , 2000, Journal of the American College of Cardiology.

[52]  M. Enriquez-Sarano,et al.  Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. , 1999, Circulation.

[53]  Jagmeet P. Singh,et al.  Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study) , 1999, The American journal of cardiology.

[54]  M. Enriquez-Sarano,et al.  Aortic regurgitation complicated by extreme left ventricular dilation: long-term outcome after surgical correction. , 1996, Journal of the American College of Cardiology.

[55]  S. Rahimtoola,et al.  Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. , 1994, The New England journal of medicine.

[56]  O. Hess,et al.  Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. , 1989, Circulation.

[57]  V. Falk,et al.  Guidelines for the management of valvular heart disease The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology ( ESC ) and the European Association for CardioThoracic Surgery ( EACTS ) , 2017 .

[58]  Thoralf M Sundt,et al.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.

[59]  Jennifer G. Robinson,et al.  ACCF/AHA TASK FORCE MEMBERS , 2013 .

[60]  J. Caro ESC/EACTS Guidelines on the management of valvular heart disease , 2012 .

[61]  H. Schäfers,et al.  Aortic valve repair leads to a low incidence of valve-related complications. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[62]  M. Jahangiri,et al.  Myocardial deformation abnormalities in patients with aortic regurgitation: a strain rate imaging study. , 2009, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[63]  M. Enriquez-Sarano,et al.  Quantitative echocardiographic determinants of clinical outcome in asymptomatic patients with aortic regurgitation: a prospective study. , 2008, JACC. Cardiovascular imaging.